文献速递生殖医学

低剂量HCG替代HMG/FSH完成corifollitropin alfa刺激降低每临床妊娠成本:随机实用性试验

Replacing HMG/FSH by low-dose HCG to complete corifollitropin alfa stimulation reduces cost per clinical pregnancy: a randomized pragmatic trial.
PubMed 文献 · Reprod Biomed Online · 2019-10-24

HCG组临床妊娠率比FSH组高38%(NNT=13),每妊娠卵巢刺激成本从FSH组的4902欧元降至HCG组的2684欧元。结论认为HCG替代HMG/FSH可显著降低IVF成本且妊娠率至少等效。

要点

  • 低剂量HCG替代HMG/FSH完成corifollitropin alfa刺激可降低卵巢刺激药物成本。
  • HCG组临床妊娠率比FSH组高38%,NNT=13。
  • 每临床妊娠卵巢刺激成本从4902欧元降至2684欧元。

核心结论

  • 使用HCG替代HMG/FSH进行卵巢刺激可显著降低IVF成本,且妊娠率至少等效。

研究设计与样本

  • HCG组从第7天起使用低剂量HCG直至至少3个卵泡直径≥17mm,FSH组使用高纯度HMG常规刺激。

主要发现

  • HCG组临床妊娠率比FSH组高38%(NNT=13)。
  • 每妊娠卵巢刺激成本从FSH组的4902欧元降至HCG组的2684欧元。
  • 常规FSH方案获得10次妊娠的卵巢刺激药物成本,采用低剂量HCG方案可获得18次妊娠。

临床怎么用

  • 在corifollitropin alfa诱导后,可考虑用低剂量HCG替代HMG/FSH完成后半程卵泡成熟以降低刺激药物成本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: The cost of IVF treatment remains high, among other factors because of the medication needed for ovarian stimulation. This study investigated the effect of using low-dose human chorionic gonadotrophin (HCG) for the second phase of follicular maturation after corifollitropin alfa induction, to replace the more expensive, either recombinant or human menopausal gonadotrophin (HMG), on the cost of ovarian stimulation. DESIGN: One hundred and five patients were randomly divided into two groups: patients in the HCG group (n = 50) received low-dose HCG from Day 7 until the diameter of at least three follicles reached 17 mm or more, while patients in the FSH group (n = 55) received conventional ovarian stimulation with highly purified HMG injections. RESULTS: The clinical pregnancy rate in the HCG group was 38% higher than in the FSH group (number needed to treat, NNT = 13). The cost per pregnancy needed for ovarian stimulation was reduced from €4902 in the FSH group to €2684 in the HCG group. Hence, the cost of ovarian stimulation medication to obtain 10 pregnancies using the conventional FSH protocol is sufficient to attain 18 pregnancies when applying the low-dose HCG protocol. CONCLUSION: This study provides evidence that using HCG instead of HMG/FSH for ovarian stimulation results in a significant reduction in the cost of IVF with, at least, an equivalent pregnancy rate.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Decleer W, Comhaire F, Balduyck J, et al. Replacing HMG/FSH by low-dose HCG to complete corifollitropin alfa stimulation reduces cost per clinical pregnancy: a randomized pragmatic trial. Reprod Biomed Online. 2019. PMID: 32057673. doi:10.1016/j.rbmo.2019.10.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。